Form 4 for KYMR Kymera Therapeutics, Inc.
Accepted 2021-12-03 00:00:00 ET · period of report 2021-12-03 · accession 0000899243-21-046845 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-12-03 | 2021-12-03 | KYMR | Jacobs Bruce N. | CFO | M - OptEx | $2.08 | +10.0K | 27.5K | +57% | +$20.8K |
| DM | 2021-12-03 | 2021-12-03 | KYMR | Jacobs Bruce N. | CFO | S - Sale+OE | $53.56 | -10.0K | 19.8K | -34% | -$535.6K |
| D | 2021-12-03 | 2021-12-03 | KYMR | Jacobs Bruce N. | CFO | M - OptEx | $0.00 | -10.0K | 189.9K | -5% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-03 | M | A | 10,000 | $2.08 | 27,514 | D | — | — | (F1) This number includes 258 shares acquired under the Registrant's employee stock purchase plan on November 30, 2021. |
| 2 | Common | Common Stock | 2021-12-03 | S | D | 300 | $55.07 | 17,514 | D | — | — | (F5) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $54.96 to $55.12. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 3 | Common | Common Stock | 2021-12-03 | S | D | 1,987 | $54.32 | 17,814 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $53.92 to $54.74. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 4 | Common | Common Stock | 2021-12-03 | S | D | 7,713 | $53.31 | 19,801 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $52.91 to $53.88. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 5 | Derivative | Stock Option (Right to Buy) | 2021-12-03 | M | D | 10,000 | $0.00 | 189,899 | D | $2.08 · — to 2029-08-28 | 10,000 Common Stock | (F6) Twenty-five percent (25%) of the shares underlying this stock option vested on July 1, 2020 and the remaining shares shall vest in equal monthly installments over the remaining thirty-six (36) months, subject to the reporting person's continued employment through each vesting date. |